PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2018.01112019254366-373Hepatitis B screening rates and reactivation in solid organ malignancy patients undergoing chemotherapy in Southern ThailandRatchapong Laiwatthanapaisan, Pimsiri Sripongpun, Naichaya Chamroonkul, Arunee Dechaphunkul, Chirawadee Sathitruangsak, Siwat Sakdejayont, Chanon Kongkamol, Teerha Piratvisuthhttp://e-cmh.org/upload/pdf/cmh-2018-0111.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2018.0111, http://e-cmh.org/upload/pdf/cmh-2018-0111.pdf
Liver International10.1111/j.1478-3231.2007.01618.x200728128-38Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysisLenna A. Martyak, Ehsan Taqavi, Sammy Saabhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1478-3231.2007.01618.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2007.01618.x/fullpdf
Journal of Hepatology10.1016/s0168-8278(16)01099-02016642S596Cost-Effectiveness Analysis of Hepatitis B Virus Screening to Prevent Hepatitis B Virus Reactivation in Patients Receiving Rituximab Based Chemotherapy for Hematologic MalignancyM. Buti, J. Crespo, R. Esteban, C. Torres, I. Oyagüez, M.Á. Casadohttps://api.elsevier.com/content/article/PII:S0168827816010990?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168827816010990?httpAccept=text/plain
Gastroenterology10.1016/s0016-5085(18)33756-920181546S-1130Sa1489 - Rates of Reactivation of Overt and Occult Hepatitis B in Patients with Chronic Hepatitis C Undergoing Daa TreatmentSevda Aghayevahttps://api.elsevier.com/content/article/PII:S0016508518337569?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508518337569?httpAccept=text/plain
Chemotherapy10.1159/0004897892018635247-252Hepatitis B Reactivation Rate Is Higher Undergoing Some Cytotoxic Chemotherapy in Patients with Solid Tumors: A Large Retrospective StudyMustafa Karaca, Deniz Tural, Emre Akar, İbrahim Çil, Savaş Bayrak, Gulsum Ozet, Orhan Kemal Yucel, Erhan Hocaoglu, Ahmet Ozethttps://www.karger.com/Article/Pdf/489789, https://www.karger.com/Article/Pdf/489789
American Journal of Infection Control10.1016/s0196-6553(05)80103-81992202112Reactivation of tuberculosis in patients undergoing solid organ transplantationhttps://api.elsevier.com/content/article/PII:S0196655305801038?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0196655305801038?httpAccept=text/plain
Annals of Oncology10.1093/annonc/mdx388.048201728v559Hepatitis B and C reactivation rates due to cytotoxic chemotherapy in patients with solid tumorsM. Karaca, D. Tural, I. Cil, G. Ozet, O.K. Yucel, A. Ozethttps://api.elsevier.com/content/article/PII:S0923753420388219?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753420388219?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx388.048/19941200/mdx388.048.pdf
Journal of Hepatology10.1016/s0168-8278(01)80483-92001340133Incidence of hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapyW Yeohttps://api.elsevier.com/content/article/PII:S0168-8278(01)80483-9?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168-8278(01)80483-9?httpAccept=text/plain
Annals of Medical Research10.5455/annalsmedres.2021.02.189202128112059Investigation of hepatitis B virus prevalence and reactivation frequency in malignancy patients administering chemotherapyMuhammet Cengiz, Yuksel Seckin, Yasir Cagin, Ayse Cengizhttps://www.ejmanager.com/fulltextpdf.php?mno=58717
Journal of Gastroenterology and Hepatology10.1111/j.1440-1746.2010.06243.x2010255864-871Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: Diagnosis and managementJohn S Lubel, Peter W Angushttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1440-1746.2010.06243.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2010.06243.x/fullpdf